News & Analysis on Clinical Trial Services & Contract Research And Development
Filtration specialists, Pall, and Biotrace have signed an agreement to market microbiological air monitoring technology to the pharmaceutical industry. The deal focuses on microbiological monitoring of manufacturing processes, which is critical to...
The break up of global fine and specialty chemicals company Avecia continued as Fujifilm said it would take over Avecia Inkjet formally next month. The €220 million fee to acquire the company's Inkjet and Electrophotography arm of the business,...
Stable Micro Systems has developed a new test for measuring the resilience of thin, film-like products that are used in pharmaceutical products including plasters, bandages, polymer film, micropore tape, synthetic skin and latex, amongst others.
Lonza has boosted its capacity to produce peptides through liquid phase technology with the €120 million acquisition of UCB's Bioproducts manufacturing division.
Large Scale Biology Corporation (LSBC) along with its subsidiaries Bioprocessing and Predictive Diagnostics, has now filed for Chapter 11 bankruptcy protection after going bust last month.
Acolyte Biomedica introduces a new platform for its MRSA test, which promises to set the benchmark for laboratory-based screening of the bacterium by confirming negatives in five hours and positives within 24 hours.
The FDA has cut red tape and modernised its guidance on experimental clinical studies to help improve and accelerate the R&D process of new compounds and ultimately get new drugs to market faster.